close
Add to watchlist
RTI Biologics Inc (RTIX) Healthcare, Healthcare Facilities
RTI Biologics, Inc., together with its subsidiaries, produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues, and improve surgical outcomes. The company processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissues, and bovine animal tissues to produce allografts for hospitals and surgeons. It processes and distributes human and bovine animal tissues for spine, sports medicine, dental, surgical specialties, bone graft substitutes, and general orthopedic markets in the United States and internationally. The company was founded in 1997 and is headquartered in Alachua, Florida.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 3.71 |
| Volume | 84826 |
| Volume Avg | 286552 |
| 52 Week High | 4.79 |
| 52 Week Low | 2.54 |
| PE | 25.47 |
| PE (group average) | 39 |
| EPS Year | 0.15 |
| EPS change Q/Q | -60% |
| EPS change Q/Q Yr ago | -100% |
| EPS change Q/Q next Q est | -50% |
| EPS change Y/Y | -1000% |
| REV change Q/Q | -10.57% |
| REV change Q/Q Yr ago | 7.41% |
| EPS next Q est | 0.04 |
| EPS next Y est | 0.22 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |